The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael H.
One or more keywords matched the following items that are connected to Davidson, Michael H.
Item TypeName
Concept Risk Assessment
Academic Article Cholesterol-lowering drugs bring benefits to high-risk populations even when LDL is normal.
Academic Article Strategies to improve Adult Treatment Panel III guideline adherence and patient compliance.
Academic Article Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Academic Article Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
Academic Article Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database.
Academic Article Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.
Academic Article The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Academic Article Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
Academic Article Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
Academic Article Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: a secondary end point of the CHICAGO study.
Academic Article Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
Academic Article Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management.
Academic Article An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Assessing cardiovascular risk one patient at a time.
Academic Article Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
Academic Article Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker.
Academic Article The use of high-sensitivity assays for C-reactive protein in clinical practice.
Academic Article Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
Academic Article Apolipoprotein measurements: is more widespread use clinically indicated?
Academic Article The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.
Academic Article Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
Academic Article Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study.
Academic Article Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
Academic Article A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Academic Article Updating the assessment of cardiac risk: beyond Framingham.
Academic Article The role of cardiologists in the management of patients with diabetes is evolving owing to the close relationship between diabetes and CAD. Introduction.
Academic Article Food additive approvals: risks vs benefits.
Academic Article Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Academic Article Economic cost of Alzheimer disease in Israel.
Academic Article Impaired diurnal blood pressure variation and all-cause mortality.
Academic Article Pharmacotherapy: Implications of high-dose statin link with incident diabetes.
Academic Article Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Academic Article Large high-density lipoprotein particle number is independently associated with microvascular function in patients with well-controlled low-density lipoprotein concentration: A vasodilator stress magnetic resonance perfusion study.
Academic Article Cardiorenal Safety of OTC Analgesics.
Academic Article How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.
Academic Article Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.
Academic Article Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
Search Criteria
  • Risk Assessment